Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospital Las Higueras

About this trial

Acute kidney injury (AKI) is common in critically ill patients and is frequently associated with fluid overload, which can worsen clinical outcomes. Continuous renal replacement therapy (CRRT) allows fluid removal through net ultrafiltration (UFNET), but some patients develop hemodynamic instability or signs of poor tissue perfusion during this process.

The purpose of this prospective observational study is to evaluate tolerance to net ultrafiltration in critically ill patients with AKI receiving CRRT. The study will assess clinical, hemodynamic, ultrasound, perfusion, and biochemical parameters before and during fluid removal to identify factors associated with ultrafiltration intolerance.

The investigators hypothesize that alterations in hemodynamic, perfusion, and congestion-related parameters can identify patients at increased risk of ultrafiltration intolerance before the development of overt hypotension. The results may help improve individualized fluid removal strategies and optimize the safety of CRRT in critically ill patients.

Eligibility criteria

Qualifiers

Age ≥18 years

Admission to an Intensive Care Unit

Acute kidney injury according to KDIGO criteria

Prescription of continuous renal replacement therapy (CRRT) with net ultrafiltration

Disqualifiers

Chronic kidney replacement therapy prior to ICU admission

Pregnancy

Limitation of therapeutic effort or goals-of-care decisions at admission or during the observation period

Inability to perform hemodynamic or perfusion assessment

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

128 Participants
are grouped into 1 trial group

Sponsors and collaborators